News

Video

Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC

Related Videos
Howard Colman, MD, PhD, Jan M. Huntsman Presidential Professor, Department of Neurosurgery, member, Brain Tumor Research Team, and leader, Center for Neurologic Cancers, Huntsman Cancer Institute, University of Utah
Charles B. Nguyen, MD